Medibios Laboratories Limited - Company Profile

It is a pharma public limited company based in Mumbai, established in 1995.
1995 Amalgamated
Last Updated:
Access Report
About Medibios Laboratories Limited

Medibios Laboratories Limited, a amalgamated public limited company, was established on 08 March 1995. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1995PLC086180. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.10 Cr.

Formerly known as Medibios Laboratories Private Limited. It upholds a compliant status. Employing 138 professional, Its leadership includes Yogesh Rajendra Gole (Director), Tushar Anil Korday (Managing Director), Sharad Kantilal Sheth (Director). Past directors included Anil Dwarkanath Korday, Shailaja Tushar Korday, Jyoti Rajendra Gole. It holds no open charges and ₹39.29 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 102, Shree Mangalam, 1St Floor, Kulupwadi, Borivali(E) India, Mumbai, Maharashtra.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1995PLC086180

  • Registration Number

    086180

  • Incorporation Date

    08 March 1995

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹7.10 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 7.10 Cr
  • Company Age 30 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 39.29 Cr
  • Revenue Growth **** -2.48%
  • Profit Growth **** -3.23%
  • Ebitda **** -0.91%
  • Net Worth 18.59%
  • Total Assets **** 20.04%
Company report

Medibios Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medibios Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medibios Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Yogesh Rajendra Gole Director 01 Nov 2011 Current
Tushar Anil Korday Managing Director 14 May 2010 Current
Sharad Kantilal Sheth Director 20 Mar 2018 Current
Meena Sanjiv Kapadi Director 20 Mar 2018 Current
Rajendra Fattesinh Gole Whole-Time Director 20 Mar 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Sep 2009 Past
Pramod Abcsdd Director 20 Mar 2018 Past
Pramod Abcsdd Director 20 Mar 2018 Past
Pramod Abcsdd Director 22 Aug 2011 Past
Pramod Abcsdd Additional Director 11 Sep 2012 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medibios Laboratories.

Medibios Laboratories Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.48% decrease. The company also saw a slight decrease in profitability, with a 3.23% decrease in profit. The company's net worth Soared by an impressive increase of 18.59%.

Medibios Laboratories revenue growth over time
Medibios Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.48%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.57%
*******
*******
*******
*******
Total Assets
*******
 20.04%
*******
*******
*******
*******
Profit or Loss
*******
 -3.23%
*******
*******
*******
*******
Net Worth
*******
 18.59%
*******
*******
*******
*******
EBITDA
*******
 -0.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medibios Laboratories?

In 2023, Medibios Laboratories had a promoter holding of 99.70% and a public holding of 0.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹392,900,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 22.29 Cr
  • Axis Bank Limited : 17.00 Cr
Latest Charge Details
Date Lender Amount Status
26 Jun 2018 Axis Bank Limited ₹17.00 Cr Satisfied
09 Nov 2000 State Bank Of India ₹2.34 Cr Satisfied
17 May 1999 State Bank Of India ₹19.95 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Medibios Laboratories?

Medibios Laboratories has a workforce of 138 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medibios Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medibios Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medibios Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    The activity Medibios Laboratories Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    Medibios Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.

  • Charges

    The activity A charge registered on 26 Jun 2018 via Charge ID 100190200 with Axis Bank Limited was fully satisfied on 04 Jun 2021. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 17.00 Cr with Charge ID 100190200 was registered on 26 Jun 2018. was documented.

  • Director Appointment

    Progress on Sangeeta Amitkumar Dhanuka was appointed as a Company Secretary was appointed as a Company Secretary on 20 Mar 2018 & has been associated with this company since 7 years 10 months . was documented.

  • Director Appointment

    Progress on Sharad Kantilal Sheth was appointed as a Director was appointed as a Director on 20 Mar 2018 & has been associated with this company since 7 years 10 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medibios Laboratories Limited?

The CIN of Medibios Laboratories Limited is U24230MH1995PLC086180.

Where is Medibios Laboratories Limited headquartered?

Medibios Laboratories Limited is headquartered at 102, Shree Mangalam, 1St Floor, Kulupwadi, Borivali(E) India, Mumbai, Maharashtra.

When was Medibios Laboratories Limited incorporated?

Medibios Laboratories Limited was incorporated on 08 March 1995.

Who are the current directors of Medibios Laboratories Limited?

The current directors of Medibios Laboratories Limited are

What is the primary industry of Medibios Laboratories Limited?

The primary industry of Medibios Laboratories Limited is Manufacturing.

Is Medibios Laboratories Limited a listed company?

Medibios Laboratories Limited is unlisted.

What is the capital structure of Medibios Laboratories Limited?

The authorized capital of Medibios Laboratories Limited is ₹10.00 Cr, and the paid-up capital is ₹7.10 Cr.

What is the compliance status of Medibios Laboratories Limited?

The compliance status of Medibios Laboratories Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available